Search

Your search keyword '"Caimmi, D P"' showing total 153 results

Search Constraints

Start Over You searched for: Author "Caimmi, D P" Remove constraint Author: "Caimmi, D P"
153 results on '"Caimmi, D P"'

Search Results

1. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

2. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

3. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

4. Work productivity in rhinitis using cell phones: The MASK pilot study

5. Operational definition of Active and Healthy Ageing (AHA): A conceptual framework

6. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

10. Les biothérapies dans l’asthme sévère de l’enfant

11. Les anticorps monoclonaux à disposition des allergologues pour traiter l'asthme sévère.

12. Prise en charge diagnostique et thérapeutique des syndromes d'activation mastocytaire.

13. Comment s'informent les patients allergiques ? Une étude exploratoire dans un CHU français.

14. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

15. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

16. Rôle des interventions non pharmacologiques dans la rhinite allergique au pollen de cyprès.

17. Evaluation of patients' expectation and benefits of sublingual Named-Patient Products in the treatment of allergic respiratory diseases: The French ERAPP prospective cohort study.

19. Recommandations pour la prescription de l'immunothérapie allergenique et le suivi du patient – méthodologie et liste des recommandations.

20. Recommandations pour la prescription de l'immunothérapie allergénique et le suivi du patient — Questions développées et revue de la littérature.

21. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

22. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (vol 6, 29, 2016)

23. L'immunothérapie allergénique par APSI : place et perspectives pour le traitement et la prévention des allergies respiratoires ; le cas des pollinoses.

24. Building Bridges for Innovation in Ageing : Synergies between Action Groups of the EIP on AHA

25. Pilot study of mobile phone technology in allergic rhinitis in European countries. The MASK-rhinitis study.

26. Work productivity in rhinitis using cell phones: The MASK pilot study.

27. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.

28. Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

29. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

30. Work productivity in rhinitis using cell phones: The MASK pilot study

31. BUILDING BRIDGES FOR INNOVATION IN AGEING: SYNERGIES BETWEEN ACTION GROUPS OF THE EIP ON AHA

32. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

33. Building Bridges for Innovation in Ageing:Synergies between Action Groups of the EIP on AHA

34. Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA

35. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

36. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies

37. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

38. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

39. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

40. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

41. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly ( MACVIA ‐ ARIA ) ‐ EIP on AHA Twinning Reference Site ( GARD research demonstration project)

42. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis study

43. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation

44. Allergie à l'hemisuccinate de methylprednisolone chez une patiente atteinte d'une dysfonction des cordes vocales à l'effort.

45. WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 – Area 5)

46. ARIA 2016 : Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

47. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

48. ARIA 2016

49. Allergy immunotherapy across the life cycle to promote active and healthy ageing

50. Erratum to: Building bridges for innovation in ageing:Synergies between action groups of the EIP on AHA

Catalog

Books, media, physical & digital resources